Therapeutic protein and antibody discovery
The therapeutic proteins and antibodies are focused on modulating G-protein-coupled receptor activity.
Source: LinkedIn company description · Retrieved October 13, 2026
Tectonic focuses on discovering and developing therapeutic proteins and antibodies that modulate G-protein-coupled receptor activity.
The company focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent. Tectonic developed the GEODe™ platform to enable discovery and development of GPCR-targeted biologic medicines.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The therapeutic proteins and antibodies are focused on modulating G-protein-coupled receptor activity.
Source: LinkedIn company description · Retrieved October 13, 2026
The GEODe™ platform enables discovery and development of GPCR-targeted biologic medicines described as capable of modifying disease course.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.